Mast Cell Leukemia (MCL)

Also known as: Malignant Mast Cell Tumors / Malignant mast cell neoplasm / Mast Cell Leukemia / Malignant mast cell tumor / Mast cell sarcoma / Malignant mast cell neoplasm (morphologic abnormality) / Mast cell sarcoma (morphologic abnormality) / Malignant mast cell tumor (disorder) / Mast-Cell Sarcoma / Mast cell leukaemia / Mast cell leukemia not having achieved remission / Mast cell leukemia (morphologic abnormality) / Leukemia, Mast-Cell / Mast cell leukemia (disorder) / Mastocytic leukaemia / Mastocytic leukemia / Malignant mastocytosis (disorder)

DrugDrug NameDrug Description
DB15233AvapritinibA selective tyrosine kinase inhibitor being investigated for the treatment of multidrug resistant gastrointestinal tumors.
DB06595MidostaurinAn antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL).